Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Meningiomas are known to be the most frequent intracranial neoplasms and account for approx. 25-33% of all intracranial tumours.Targeted radionuclide therapy with radiolabelled somatostatin analogues, also called Peptide Receptor Radionuclide Therapy (PRRT), has proven to be an effective treatment in metastatic intestinal neuroendocrine tumours and is currently used in advanced, …

karnofsky performance status
ct scan
somatostatin
dotatoc
peptide receptor radionuclide therapy
  • 0 views
  • 18 Aug, 2021
  • 1 location
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

The purpose of the study is to understand the extent and degree of somatostatin receptor expression in poorly differentiated neuroendocrine carcinomas . This may help to make a determination if a radiolabeled somatostatin analog therapy, also referred to as peptide receptor radiotherapy (PRRT), can be a potential alternative in the …

somatostatin
18f-fdg
positron emission tomography
dotatate
measurable disease
  • 1 views
  • 10 Mar, 2022
  • 1 location
PET Imaging in Patients With Suspected Cardiac Sarcoidosis

Gallium-68 DOTATATE is a radioactive tracer, a type of imaging drug that is labeled with a radioactive tag and injected into the body, which is approved by the U.S. Food and Drug Administration

  • 0 views
  • 15 Feb, 2021
  • 1 location
Spanish Series of Patients Treated With the Radionuclide Lutetium177

This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice

  • 0 views
  • 09 Jul, 2021
  • 19 locations
Natural History of Familial Carcinoid Tumor

This study will evaluate members in families with a history of small bowel carcinoid cancer to study the natural history of those family members that have the disease, determine ways to improve early detection by performing surveillance on those at risk but without disease and to identify the gene(s) that …

positron emission tomography
neuroendocrine tumor
cancer
pet/ct scan
  • 5 views
  • 14 May, 2022
  • 1 location
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

diagnostic utility of 68Ga-DOTATATE PET/MRI in the diagnosis and management of patients with SSTR-positive CNS tumors, specifically whether 68Ga-DOTATATE PET/MRI demonstrates utility distinguishing between

MRI Scan
3t mri
cancers metastatic
medulloblastoma
stereotactic radiosurgery
  • 0 views
  • 10 Oct, 2021
Residual Inflammation and Plaque Progression Long-term Evaluation (RIPPLE)

(MI) remain at increased risk of recurrent events. The RIPPLE study aims to examine the relationship between residual coronary inflammation detected by 68Ga-DOTATATE PET in patients treated for MI to

coronary ct
angiography
coronary artery disease
infarction
atherosclerosis
  • 0 views
  • 24 Apr, 2022
  • 1 location
Using 18F- FDG 18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT

the investigators will follow up after patients with neuroendocrine tumors who undergo PRRT treatment and evaluate the response for treatment using PET/CT with different tracers

  • 0 views
  • 27 Jan, 2021
  • 1 location
Optimising Molecular Radionuclide Therapy (SELFIE)

This project will examine the role of the whole body, PET and SPECT imaging before, during and after radionuclide treatment for 177Lu-Dotatate therapy, whole body and SPECT imaging for 131-I for

ct scan
  • 0 views
  • 21 Mar, 2022
PET Imaging of Giant Cell and Takayasu Arteritis

While 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging is often included in the diagnostic work-up of patients with large-vessel vasculitis (LVV), 18F-FDG lacks specificity for inflammatory cells and has limited ability to track therapy response. Moreover, high background 18F-FDG uptake in the brain and myocardium largely precludes imaging temporal arteritis …

  • 0 views
  • 05 Jul, 2021
  • 2 locations